ABSTRACTS SELECTED AS E-POSTERS
IN ALPHABETIC ORDER ACCORDING TO THE NAME OF THE FIRST
AUTHOR
TRIALS IN PROGRESS POSTERS
Poster 25: PHASE 3 STUDY OF LENALIDOMIDE (LEN) VS PLACEBO IN NON-TRANSFUSION
DEPENDENT (TD) LOW RISK MDS DEL(5Q) PATIENTS.
INTERIM ANALYSIS OF THE EUROPEAN SINTRA-REV TRIAL.
Félix López-Cadenas1, Eva Lumbreras2, Bianca Xicoy3, Joaquín Sánchez4, Rosa
Coll5, Slama Borhane6, Jose Ángel Hernández7, Sylvain Thepot8, Teresa Bernal
Del Castillo9, Beatriz Arrizabalaga10, Agnès Guerci-Bresler11, Guillermo Sanz12,
Juan Bargay13, Maria Luz Amigo14, Raquel De Paz Arias15, Benet Nomdedeu16,
Aristoteles Giagounidis17, Uwe Platzbecker18, Stefan Wickenhauser19,
Katharina Götze20, Ali Arar21, Jesús-María Hernández-Rivas1, Pierre Fenaux22,
Consuelo del Cañizo23 and María Díez-Campelo1
Poster 26: THE STIMULUS-MDS TRIALS: TWO CLINICAL TRIALS EVALUATING
SABATOLIMAB (MBG453) COMBINATION THERAPY IN PATIENTS (PTS)
WITH HIGHER-RISK MYELODYSPLASTIC SYNDROMES (HR-MDS)
Amer Zeidan1, Aristoteles Giagounidis2, Yasushi Miyazaki3, Uwe Platzbecker4,
Mikkael A. Sekeres5, Zhijian Xiao6, Kamel Malek7, Marlies Van Hoef7, Julie
Niolat8, Fei Ma9, Flavia Kiertsman9, Sabine Hertle7, Pierre Fenaux10 and Valeria
Santini11